HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jessica N McAlpine Selected Research

Tubal Sterilization (Tubal Ligation)

12/2023Complications after opportunistic salpingectomy compared with tubal ligation at cesarean section: a retrospective cohort study.
11/2023Opportunistic Salpingectomy Between 2017 and 2020: A Descriptive Analysis.
4/2022Opportunistic salpingectomy between 2011 and 2016: a descriptive analysis.
1/2022Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention.
1/2020Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
1/2018Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
4/2015Population distribution of lifetime risk of ovarian cancer in the United States.
2/2015Costs and benefits of opportunistic salpingectomy as an ovarian cancer prevention strategy.
1/2015Opportunistic salpingectomy for ovarian cancer prevention.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jessica N McAlpine Research Topics

Disease

44Neoplasms (Cancer)
02/2024 - 10/2006
30Endometrial Neoplasms (Endometrial Cancer)
02/2024 - 05/2005
27Ovarian Neoplasms (Ovarian Cancer)
12/2023 - 04/2007
14Carcinoma (Carcinomatosis)
01/2020 - 12/2009
4Endometrioid Carcinoma
01/2020 - 01/2014
3Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer)
12/2022 - 01/2017
3Turcot syndrome
01/2020 - 01/2017
3Ovarian Epithelial Carcinoma
01/2016 - 04/2007
2Infections
12/2023 - 01/2018
2Microsatellite Instability
01/2023 - 01/2020
2Mucinous Adenocarcinoma (Mucinous Carcinoma)
11/2017 - 12/2009
2Sarcoma (Soft Tissue Sarcoma)
07/2015 - 01/2012
1Polyps
02/2024
1Residual Neoplasm
02/2024
1Uterine Diseases (Endometrial Disease)
02/2024
1Anemia
12/2023
1Hyperplasia
11/2022
1Hemorrhage
01/2022
1Obesity
01/2022
1Endometrial Hyperplasia
11/2020
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2020
1Small Cell Carcinoma
01/2020
1Breast Neoplasms (Breast Cancer)
10/2019
1Rupture
11/2017
1Granulosa Cell Tumor
01/2017
1Carcinosarcoma
07/2015
1Uterine Neoplasms (Uterine Cancer)
07/2015
1Genetic Risk Score
04/2015
1Endometriosis
04/2015
1Margins of Excision
01/2015
1Inflammation (Inflammations)
05/2012
1Ascites
05/2012
1Endometrial Stromal Sarcoma
01/2012

Drug/Important Bio-Agent (IBA)

11Proteins (Proteins, Gene)FDA Link
07/2023 - 07/2015
9DNA (Deoxyribonucleic Acid)IBA
01/2023 - 02/2011
8PlatinumIBA
01/2022 - 10/2006
8Biomarkers (Surrogate Marker)IBA
01/2021 - 04/2013
7Exonucleases (3' 5' Exonuclease)IBA
01/2021 - 09/2015
5DNA Polymerase IIIBA
07/2023 - 10/2017
4Carboplatin (JM8)FDA LinkGeneric
02/2011 - 10/2006
3Estrogen ReceptorsIBA
06/2023 - 11/2020
3ParaffinIBA
01/2023 - 04/2013
3RNA (Ribonucleic Acid)IBA
11/2022 - 04/2013
3Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022 - 08/2008
2Anti-Bacterial Agents (Antibiotics)IBA
12/2023 - 01/2018
2Analgesics (Analgesic Drugs)IBA
12/2023 - 01/2018
2Formaldehyde (Formol)FDA Link
01/2023 - 12/2014
2Protein Isoforms (Isoforms)IBA
11/2022 - 01/2020
2Type 2 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 2)IBA
11/2022 - 01/2020
2Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
01/2020 - 01/2018
2Hematoxylin (Haematoxylon)IBA
07/2016 - 01/2015
2Eosine Yellowish-(YS) (Eosin)IBA
07/2016 - 01/2015
2Estrogens (Estrogen)FDA Link
06/2016 - 07/2015
2Capsules (Microcapsules)IBA
01/2011 - 08/2008
2Paclitaxel (Taxol)FDA LinkGeneric
12/2009 - 08/2008
1Dihydrotachysterol (AT 10)IBA
12/2022
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2022
1Messenger RNA (mRNA)IBA
11/2022
1LCL161IBA
01/2022
1ProteomeIBA
01/2021
1Epidermal Growth Factor (EGF)IBA
01/2021
1ProgesteroneFDA LinkGeneric
11/2020
1Progestins (Progestagens)IBA
11/2020
1taxaneIBA
01/2020
1ADI PEG20IBA
01/2020
1Arginine (L-Arginine)FDA Link
01/2020
1Argininosuccinate Synthase (Argininosuccinate Synthetase)IBA
01/2020
1Collagenases (Collagenase)FDA Link
10/2019
1Peptide Hydrolases (Proteases)FDA Link
10/2019
1Small Cytoplasmic RNAIBA
10/2019
1Retroelements (Retrotransposon)IBA
10/2019
1CystathionineIBA
01/2017
1LyasesIBA
01/2017
1Circulating Tumor DNAIBA
01/2017
1Hormones (Hormone)IBA
06/2016
1Progesterone Receptors (Progesterone Receptor)IBA
06/2016
12,5- dibromo- 2- (beta- naphthyl)indan- 1,3- dioneIBA
05/2016
1VimentinIBA
11/2015
1Oral ContraceptivesIBA
04/2015
114-3-3 Proteins (14-3-3 Protein)IBA
01/2012
1Oncogene Proteins (Oncogene Protein)IBA
01/2012

Therapy/Procedure

20Therapeutics
02/2024 - 12/2009
15Drug Therapy (Chemotherapy)
12/2022 - 04/2007
13Hysterectomy
02/2024 - 05/2005
12Salpingectomy
12/2023 - 05/2012
9Tubal Sterilization (Tubal Ligation)
12/2023 - 01/2015
4Radiotherapy
02/2024 - 11/2017
3Salpingo-oophorectomy
07/2020 - 07/2011
2Precision Medicine
12/2021 - 01/2019
2Gynecologic Surgical Procedures (Gynecologic Surgery)
01/2020 - 01/2018
2Adjuvant Radiotherapy
01/2019 - 11/2017
2Neoadjuvant Therapy
05/2012 - 04/2007
1Patient Readmission
12/2023
1Cesarean Section (Caesarean Section)
12/2023
1Length of Stay
12/2023
1Contraception (Birth Control)
12/2023
1Immunotherapy
04/2019
1Operative Surgical Procedures
12/2017
1Ovariectomy (Oophorectomy)
01/2015
1Laparotomy
08/2011